PR-FAMPRIDINE IMPROVES WALKING SPEED AND QUALITY OF LIFE IN MS

被引：0
|
作者：
Ewe, Renee [1 ]
Louissaint, Hannah [2 ]
Bull, Kate [2 ]
Allen, Joanne [2 ]
Farrell, Rachel [1 ,2 ]
机构：
[1] UCL, London, England
[2] UCLH, NHNN, London, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2017年 / 88卷
关键词：
D O I：
10.1136/jnnp-2017-ABN.155
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PO125
引用
收藏
页码：A45 / A45
页数：1
相关论文
共 50 条
  • [1] PR-Fampridine improves walking and quality of life in people with severe MS-related walking impairment
    Ewe, R.
    Louissaint, H.
    Bleasdale, H.
    Bull, K.
    Farrell, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 332 - 332
  • [2] PR-Fampridine improves walking and quality of life in people with MS. A pragmatic observational study
    Flisher, L.
    Christofi, G.
    Koch, M.
    Wilkinson, H.
    Norman, S.
    Stevenson, V.
    Farrell, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 1004 - 1004
  • [3] Longitudinal study of the effect of PR-fampridine walking and quality of life in people with severe MS-related walking impairment
    Ewe, R. A. L.
    Farrell, R.
    Louissaint, H.
    Bleasdale, H.
    Bull, K.
    Beare, B.
    Allen, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 691 - 691
  • [4] PR-fampridine and improvement of walking: it's clinically meaningful in daily practice
    Prugger, M.
    Berger, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 247 - 248
  • [5] Safety, Quality Of Life, and Walking Ability with PR-Fampridine Treatment in Clinical Practice in France: Interim Results of The LIBERATE Study
    Yeh, M.
    Neau, J. P.
    Castelnovo, G.
    Soisson, T.
    Kwiatkowski, A.
    McNeill, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 805 - 806
  • [6] MS PATIENTS' PERCEPTION OF THE EFFECTS OF PR-FAMPRIDINE ON WALKING DISORDERS AND DAILY LIFE: RESULTS FROM AN OBSERVATIONAL STUDY CONDUCTED VIA AN ONLINE PATIENT COMMUNITY
    Simon, O.
    Wilczynski, O.
    Jomaa, K.
    [J]. VALUE IN HEALTH, 2018, 21 : S353 - S353
  • [7] Clinically meaningful change of walking assessments in patients with multiple sclerosis treated with PR-fampridine
    Sola-Valls, N.
    Blanco, Y.
    Sepulveda, M.
    Llufriu, S.
    Martinez-Lapiscina, E. H.
    Zubizarreta, I.
    La Puma, D.
    Graus, F.
    Villoslada, P.
    Saiz, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 126 - 126
  • [8] MOBILE/ENHANCE INTEGRATED EFFICACY ANALYSIS OF PR-FAMPRIDINE
    Hupperts, Raymond
    Hobart, Jeremy
    Gasperini, Claudio
    Lycke, Jan
    Ziemssen, Tjalf
    Feys, Peter
    McNeill, Manjit
    Acosta, Carlos
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : E57 - E58
  • [9] Combined T25FW and MSWS12 response improves identification of persistent response to PR-Fampridine in people with MS
    Ewe, R. A. L.
    Louissaint, H.
    Bull, K.
    Allen, J.
    Hare, N.
    Johnson, J.
    Farrell, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 421 - 421
  • [10] Health-related quality of life improved in people with multiple sclerosis who had clinically meaningful changes in walking ability with PR-Fampridine: Post hoc analysis of enhance
    Hobart, J.
    Hupperts, R.
    Linnebank, M.
    Acosta, C.
    McNeill, M.
    Lima, G.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 452 - 452
12345